Legal Representation
Attorney
John Patrick Sullivan
USPTO Deadlines
Application History
39 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 9, 2021 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Sep 9, 2021 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Feb 25, 2021 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Feb 25, 2021 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Feb 25, 2021 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Feb 6, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 5, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 5, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 5, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Feb 5, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Feb 5, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 5, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 5, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Aug 13, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Aug 13, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Aug 13, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 13, 2020 | WOAR | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | Loading... |
| Aug 13, 2020 | WOAG | I | WITHDRAWAL OF ATTORNEY GRANTED | Loading... |
| Aug 6, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 6, 2020 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 6, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 22, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 22, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 20, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 8, 2020 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Jul 8, 2020 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Jul 8, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 8, 2020 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Mar 16, 2020 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Mar 16, 2020 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Sep 1, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 1, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 1, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 23, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 18, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 18, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 17, 2019 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jan 16, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 27, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for treatment of opioid addiction with pain management; Pharmaceutical preparations for cancer tumor cell remediation; Pharmaceutical preparations, namely, antidepressants; Anti-epileptic pharmaceutical preparations; Pharmaceutical preparations for cancer tumor cell remediation; Pharmaceutical preparations in the form of topical analgesics, tinctures, namely, medicinal herb extracts, and herbal anti-inflammatory salves for treating chemical imbalances, inflammation, epilepsy, depression, cancer, and opioid addiction with pain management; all of the foregoing containing or solely derived from CBD derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; anti-epileptic pharmaceutical preparations containing no CBD
First Use Anywhere:
Oct 6, 2018
First Use in Commerce:
Dec 20, 2018
Class 044
Dispensing of pharmaceuticals containing or solely derived from hemp with a delta-9 tetrahydrocannabinol THC concentration of not more than 0.3 percent on a dry weight basis; Dispensing of pharmaceuticals containing no CBD
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of Greek cross where the upper and right arms of the cross are shaded darker than the left and lower arms of the cross; there is a break at the base of the upper arm of the cross; the Greek cross is followed by the letters FARMACEUTICALRX.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
PHARMACEUTICAL RX
Classification
International Classes
005
044